Opportunities and Challenges in Biologic Drug Delivery

摘要

Biologic drugs have been called the driving force in pharma for good reason. They comprise more than half of drugs in development, and they have the potential to address many chronic diseases and various unmet medical needs. Some of the first biologics to come to market, among them Abbvie's Humira and Roche's Rituxan, quickly became multibillion dollar blockbusters. It's no wonder pharmaceutical companies are racing to bring biologics and biosimilars to market.